|
2010
|
Invention
|
Treatment of organophosphate exposure with tetrahydroindolone arylpiperazine compounds.
A method... |
|
|
Invention
|
Compositions and methods for preparation of poorly water soluble drugs with increased stability. ... |
|
|
Invention
|
Tetrahydroindolone derivatives for treatment of neurological conditions. Compositions comprising ... |
|
2009
|
Invention
|
Treatment of organophosphate exposure with tetrahydroindolone arylpiperazine compounds.
|
|
2008
|
Invention
|
Treatment of post-traumatic stress disorder with tetrahydroindolone arylpiperzaine compounds.
Te... |
|
|
Invention
|
Propofol analogs, process for their preparation, and methods of use. The invention provides para ... |
|
|
Invention
|
Sparc and methods of use thereof. The invention provides methods of treating a mammalian tumors c... |
|
|
Invention
|
Sparc and methods of use thereof.
The invention provides methods of treating a mammalian tumors ... |
|
2007
|
Invention
|
Q3 sparc deletion mutant and uses thereof.
The invention provides for SPARC polypeptides with a ... |
|
|
Invention
|
Triazine derivatives and their therapeutical applications. The invention provides for Triazine de... |
|
|
Invention
|
Dicarbonyl derivatives and methods of use. Derivatives of dicarbonyl compounds having antitumor a... |
|
|
Invention
|
Derivatives of 18-amino substituted analogs of the geldamycin hydroquinon with cytotoxic activity... |
|
|
Invention
|
Sparc and methods of use thereof. The invention provides methods for predicting or determining th... |
|
2006
|
Invention
|
Novel formulations of pharmacological agents, methods for the preparation thereof and methods for... |
|
|
Invention
|
Geldanamycin derivatives and pharmaceutical compositions thereof. The invention provides novel ge... |
|
|
Invention
|
Combretastatin derivatives and related therapeutic methods. Compounds of the formula (I) wherein ... |
|
|
Invention
|
Methods and formulations of taxanes.
In accordance with the present invention, there are provide... |
|
|
Invention
|
Drugs with improved hydrophobicity for incorporation in medical devices.
The invention provides ... |
|
|
Invention
|
Drugs with improved hydrophobicity for incorporation in medical devices. The invention provides a... |
|
|
Invention
|
Combinations and modes of administration of therapeutic agents and combination therapy. The prese... |
|
|
Invention
|
Q3 sparc deletion mutant and uses thereof. The invention provides for SPARC polypeptides with a m... |
|
|
Invention
|
Compositions, methods of use and preparation of 2,6-diisopropyl phenol and analogs for ischemic i... |
|
2005
|
Invention
|
Methods and formulations for delivery of pharmacologically active agents.
In accordance with the... |
|
|
Invention
|
Compositions and methods for the preparation and administration of poorly water soluble drugs. St... |
|
|
Invention
|
A method using inorganic nanoparticles as non-viral vectors for gene therapy. A method of treatin... |
|
|
Invention
|
Treatment methods utilizing albumin-binding proteins as targets. The invention provides a method ... |
|
2004
|
Invention
|
Propofol analogs, process for their preparation, and methods of use.
The invention provides para... |
|
|
Invention
|
Substituted melatonin derivatives, process for their preparation, and methods of use. The inventi... |
|
|
Invention
|
Substituted melatonin derivatives, process for their preparation, and methods of use.
... |
|
|
Invention
|
Tetrahydroindolone derivatives for treament of neurological conditions. Compositions comprising t... |
|
|
Invention
|
Tetrahydroindolone derivatives for treatment of neurological conditions.
Compositions ... |
|
2003
|
Invention
|
Liquid injectable formulation of disodium pamidronate. The present invention relates to an improv... |
|
|
Invention
|
Methods and compositions useful for administration of chemotherapeutic agents. In accordance with... |
|
2002
|
Invention
|
Methods and formulations for delivery of pharmacologically active agents. In accordance with the ... |
|
|
Invention
|
Methods and formulations for the delivery of pharmacologically active agents. In accordance with ... |
|
1987
|
Invention
|
Aqueous nitroglycerin injection and manufacturing process. Nitroglycerin injection that is free o... |
